Translator Disclaimer
1 April 2002 Safety Studies of the Oral Rabies Vaccine SAD B19 in Striped Skunk (Mephitis mephitis)
Author Affiliations +
Abstract

Safety of the modified live rabies virus vaccine, SAD B19, was studied in striped skunks (Mephitis mephitis). Seven skunks received 107.9 foci formatting units by direct oral administration. In four cages, a vaccinated animal was placed with a control animal, the other three vaccinated skunks were housed individually. Saliva and nasal swabs were collected 1, 2, 4, 24, 48, and 72 hr post-vaccination. From all vaccinated and control animals (n = 11) blood samples were collected 0, 28, 56, 84, and 296 days post-vaccination. Three of seven vaccinated skunks seroconverted. None of the control animals had detectable levels of rabies virus neutralizing antibodies. Also no vaccine virus was isolated from the nasal and saliva swabs collected from any animal. Thus, SAD B19 was innocuous for skunks in our study after direct oral administration at field concentration.

Vos, Pommerening, Neubert, Kachel, and Neubert: Safety Studies of the Oral Rabies Vaccine SAD B19 in Striped Skunk (Mephitis mephitis)
A. Vos, E. Pommerening, L. Neubert, S. Kachel, and A. Neubert "Safety Studies of the Oral Rabies Vaccine SAD B19 in Striped Skunk (Mephitis mephitis)," Journal of Wildlife Diseases 38(2), 428-431, (1 April 2002). https://doi.org/10.7589/0090-3558-38.2.428
Received: 10 January 2001; Published: 1 April 2002
JOURNAL ARTICLE
4 PAGES


SHARE
ARTICLE IMPACT
Back to Top